007390 — NatureCell Co Income Statement
0.000.00%
- KR₩658bn
- KR₩630bn
- KR₩19bn
Annual income statement for NatureCell Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 23,072 | 16,720 | 22,204 | 21,252 | 19,351 |
Cost of Revenue | |||||
Gross Profit | 12,902 | 7,600 | 9,374 | 9,099 | 8,195 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 22,062 | 31,428 | 36,468 | 28,572 | 30,093 |
Operating Profit | 1,010 | -14,708 | -14,264 | -7,320 | -10,742 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 902 | -18,870 | -32,031 | -8,316 | -11,571 |
Provision for Income Taxes | |||||
Net Income After Taxes | 902 | -18,870 | -32,031 | -8,316 | -11,438 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 902 | -18,870 | -32,031 | -6,814 | -11,680 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 902 | -18,870 | -32,031 | -6,814 | -11,680 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 29.4 | -173 | -441 | -159 | -175 |
Dividends per Share |